Cardinal Health initiated with an Underperform at Wolfe Research. Wolfe Research initiated Cardinal Health with an Underperform and $45 price target citing high consensus expectations despite the upcoming CVS contract expiration.
https://thefly.com/landingPageNews.php?id=2887447
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.